173 related articles for article (PubMed ID: 17875761)
1. Pravastatin Inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats.
Haydont V; Bourgier C; Pocard M; Lusinchi A; Aigueperse J; Mathé D; Bourhis J; Vozenin-Brotons MC
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5331-40. PubMed ID: 17875761
[TBL] [Abstract][Full Text] [Related]
2. Specific signals involved in the long-term maintenance of radiation-induced fibrogenic differentiation: a role for CCN2 and low concentration of TGF-beta1.
Haydont V; Riser BL; Aigueperse J; Vozenin-Brotons MC
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1332-41. PubMed ID: 18400984
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression.
Bourgier C; Haydont V; Milliat F; François A; Holler V; Lasser P; Bourhis J; Mathé D; Vozenin-Brotons MC
Gut; 2005 Mar; 54(3):336-43. PubMed ID: 15710979
[TBL] [Abstract][Full Text] [Related]
4. Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protection.
Haydont V; Gilliot O; Rivera S; Bourgier C; François A; Aigueperse J; Bourhis J; Vozenin-Brotons MC
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1471-82. PubMed ID: 17674977
[TBL] [Abstract][Full Text] [Related]
5. Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives.
Haydont V; Mathé D; Bourgier C; Abdelali J; Aigueperse J; Bourhis J; Vozenin-Brotons MC
Radiother Oncol; 2005 Aug; 76(2):219-25. PubMed ID: 16046020
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the Rho/ROCK pathway in heart and lung after thorax irradiation reveals targets to improve normal tissue toxicity.
Monceau V; Pasinetti N; Schupp C; Pouzoulet F; Opolon P; Vozenin MC
Curr Drug Targets; 2010 Nov; 11(11):1395-404. PubMed ID: 20583978
[TBL] [Abstract][Full Text] [Related]
7. Rho/ROCK pathway as a molecular target for modulation of intestinal radiation-induced toxicity.
Haydont V; Bourgier C; Vozenin-Brotons MC
Br J Radiol; 2007 Sep; 80 Spec No 1():S32-40. PubMed ID: 17704324
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein 2 activation by pravastatin reinforces epithelial integrity and ameliorates radiation-induced enteropathy.
Kwak SY; Jang WI; Park S; Cho SS; Lee SB; Kim MJ; Park S; Shim S; Jang H
EBioMedicine; 2021 Nov; 73():103641. PubMed ID: 34688032
[TBL] [Abstract][Full Text] [Related]
10. The Rho-ROCK system as a new therapeutic target for preventing interstitial fibrosis.
Moriyama T; Nagatoya K
Drug News Perspect; 2004; 17(1):29-34. PubMed ID: 14993932
[TBL] [Abstract][Full Text] [Related]
11. Molecular aspects of intestinal radiation-induced fibrosis.
Gervaz P; Morel P; Vozenin-Brotons MC
Curr Mol Med; 2009 Apr; 9(3):273-80. PubMed ID: 19355909
[TBL] [Abstract][Full Text] [Related]
12. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
[TBL] [Abstract][Full Text] [Related]
13. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
14. Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins).
Goppelt-Struebe M; Hahn A; Iwanciw D; Rehm M; Banas B
Mol Pathol; 2001 Jun; 54(3):176-9. PubMed ID: 11376131
[TBL] [Abstract][Full Text] [Related]
15. CCN2, connective tissue growth factor, stimulates collagen deposition by gingival fibroblasts via module 3 and alpha6- and beta1 integrins.
Heng EC; Huang Y; Black SA; Trackman PC
J Cell Biochem; 2006 May; 98(2):409-20. PubMed ID: 16440322
[TBL] [Abstract][Full Text] [Related]
16. Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, inhibits cardiac myocyte hypertrophy induced by endothelin.
Nishikimi T; Tadokoro K; Wang X; Mori Y; Asakawa H; Akimoto K; Yoshihara F; Horio T; Minamino N; Matsuoka H
Eur J Pharmacol; 2002 Oct; 453(2-3):175-81. PubMed ID: 12398901
[TBL] [Abstract][Full Text] [Related]
17. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (pravastatin) inhibits endothelial cell proliferation dependent on G1 cell cycle arrest.
Asakage M; Tsuno NH; Kitayama J; Kawai K; Okaji Y; Yazawa K; Kaisaki S; Takahashi K; Nagawa H
Anticancer Drugs; 2004 Jul; 15(6):625-32. PubMed ID: 15205608
[TBL] [Abstract][Full Text] [Related]
18. Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes.
Takaguri A; Satoh K; Itagaki M; Tokumitsu Y; Ichihara K
J Pharmacol Sci; 2008 May; 107(1):80-9. PubMed ID: 18469500
[TBL] [Abstract][Full Text] [Related]
19. Pravastatin normalizes endothelium-derived contracting factor-mediated response via suppression of Rho-kinase signalling in mesenteric artery from aged type 2 diabetic rat.
Ishida K; Matsumoto T; Taguchi K; Kamata K; Kobayashi T
Acta Physiol (Oxf); 2012 Jun; 205(2):255-65. PubMed ID: 22212448
[TBL] [Abstract][Full Text] [Related]
20. MiR-210: A potential therapeutic target against radiation-induced enteropathy.
Hamama S; Noman MZ; Gervaz P; Delanian S; Vozenin MC
Radiother Oncol; 2014 May; 111(2):219-21. PubMed ID: 24290534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
